Hope for Huntington's: new drug aims to slow decline in major trial
Disease control
Not yet recruiting
This study tests whether the drug pridopidine can slow the worsening of Huntington's disease (HD) in adults. About 400 participants will take either pridopidine or a placebo twice daily for one year, then everyone can receive pridopidine for two more years. The goal is to see if …
Phase: PHASE3 • Sponsor: Prilenia • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC